Carregant...
The Ral GTPase pathway in metastatic bladder cancer: key mediator and therapeutic target
Bladder cancer is a relatively common and strikingly costly malignancy. Here, we will focus on recent advances in our understanding of the molecular pathogenesis of metastatic bladder cancer, a stage of this disease curable in only a minority of patients. Our group has recently investigated the role...
Guardat en:
| Autors principals: | , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2009
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3904428/ https://ncbi.nlm.nih.gov/pubmed/19111797 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.urolonc.2008.04.012 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|